key: cord-271734-1cfhjuxi authors: Vergkizi, Souzan; Nikolakakis, Ioannis title: Bacillus Calmette–Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally date: 2020-10-16 journal: Vaccine DOI: 10.1016/j.vaccine.2020.10.009 sha: doc_id: 271734 cord_uid: 1cfhjuxi This work demonstrates the presence of immune regulatory cells in the cervical lymph nodes draining Bacillus Calmette-Guérin (BCG) vaccinated site on the dorsum of the ear in guinea pigs. It is shown that whole cervical lymph node cells did not proliferate in vitro in the presence of soluble mycobacterial antigens (PPD or leprosin) despite being responsive to whole mycobacteria. Besides, T cells from these lymph nodes separated as a non-adherent fraction on a nylon wool column, proliferated to PPD in the presence of autologous antigen presenting cells. Interestingly, addition of as low as 20% nylon wool adherent cells to these, sharply decreased the proliferation by 83%. Looking into what cells in the adherent fraction suppressed the proliferation, it was found that neither the T cell nor the macrophage enriched cell fractions of this population individually showed suppressive effect, indicating that their co-presence was necessary for the suppression. Since BCG induced granulomas resolve much faster than granulomas induced by other mycobacteria such as Mycobacterium leprae the present experimental findings add to the existing evidence that intradermal BCG vaccination influences subsequent immune responses in the host and may further stress upon its beneficial role seen in Covid-19 patients. Regulatory cells play an important role in the control of immune responses. Under optimal conditions, immunocompetent cells help, amplify or suppress the activity of other cells so that any foreign material or invading pathogen are eradicated with minimum damage to the host. Lapses of such regulation could lead to excess detriment to the body or susceptibility of the host to the invader. Normally, under average conditions of antigenic stimulation, the immunostimulatory and suppressor activities are in equilibrium. What conditions decide which of the two mechanisms should choose to occur depends on the host and the occurring infection and are still under investigation. Furthermore, it is now generally accepted that the immune response is a collaborative result involving different populations and subpopulations of cells [1] . Helper function to humoral and cellular immunity has been ascribed to subpopulations of T cells, macrophages, dendritic cells and even B cells [2] . On the other hand, suppression of the two types of immunity has been thought to be regulated by mainly regulatory T cells (former suppressor T cells), certain populations of monocytes/macrophages and B cells [3] [4] [5] . In a number of diseases that are associated with low cell mediated immunity, T regulatory (suppressor) cells play an important role, either on their own or in combination with other cells [6] [7] [8] . Macrophages may be either stimulatory or inhibitory in immunological reactions and exhibit both pathogenic and protective roles [9] [10] [11] [12] . They not only present antigens to mainly T and B cells but also secrete several cytokines which direct the responses of other immunoregulatory cells. The three major functions of macrophages include degradation of non-self or foreign material including apoptotic or necrotic cells, initiation and enhancement of the immunological activation of lymphocytes and, mediation of suppression [13, 14] . Macrophages may cause suppression either by helping the generation of other suppressor cells [15, 16] or, by releasing immune suppressive factors such as prostaglandins [17, 18] and immunoregulatory cytokines such as interleukin-10 These factors in turn, cause the limitation of extensive tissue damage by diminishing the production of inflammatory mediators that cause specific and unspecific immune reactions [19] . B cells may also cause suppression under certain immunological conditions. Involvement of B suppressor cells was demonstrated in delayed type hypersensitivity responses to antigens such as ovalbumin, 2,4-dinitro-1-fluorobenzene and Keyhole limpet haemocyanin among others [20] [21] [22] . They may act through a negative feedback by specific antibodies or through the induction of suppressor T cells [23] . Their involvement in autoimmune diseases such as multiple sclerosis through memory cell function has also been stressed [24] . The granulomas induced by BCG are very different from those induced by Mycobacterium leprae (M. leprae) in the guinea pig and have been extensively studied for their immune responsive effects. BCG induces an 'immunological' epithelioid cell granuloma that shows containment, successful killing and degradation. Here the mononuclear phagocyte series take the form of epithelioid cells with extensive rough endoplasmic reticulum. On the other hand, M. leprae forms a 'non-immunological' macrophage-type granuloma that shows absence of organization of cells with failure to completely degrade. There is no evidence of epithelioid cell formation but the presence of undifferentiated macrophages that remain loaded with mycobacteria [25] . The BCG vaccine has been used for nearly a century now for protection against tuberculosis but, it also protects against leprosy at a varying magnitude [26] . Recent interest in BCG was triggered because of its relation to the reduction in the severity and the mortality rate of Covid-19 patients that were vaccinated [27] [28] [29] [30] [31] and, this has been associated with trained immunity [28, 32] . According to some reports BCG may be an option to enhance immunity of at-risk populations such as the elderly and healthcare workers for Covid-19 disease [33] [34] [35] . The objective of this work was to investigate the immune regulatory mechanism responsible for the induction of an 'immunological' type granuloma in the draining lymph node after BCG vaccination in guinea pigs and their early resolution in contrast to that observed with another mycobacterium, M. leprae. Outbred Dunkin Hartley strain of guinea pigs of either sex were from David Hall, Newchurch, Staffs UK. They were fed on RGP pelleted diet (C.F. Dixon and sons, Ware, Herts) supplemented with cabbage and hay. Protocols covering the use of animals were followed strictly according to the Legislation for Animal Research of 'The Animal (Scientific Procedures) Act, UK 1986 0 . Concanavalin A (Con A, Pharmacia Fine Chemicals, Sweden) was dissolved in phosphate buffered saline at a concentration of 1.5 mg/ml, filter sterilized and stored in aliquots at À20°C until use. PPD (tuberculin purified protein derivative, Central Veterinary Laboratory, Weybridge, UK) À 2 mg/ml was dialyzed against 20 volumes of PBS at 4°C for 24 h. It was filter sterilized and stored in aliquots of 0.25 ml at À20°C. Leprosin, a soluble extract of M. leprae was obtained from the Clinical Research Center, Harrow, London. Live Bacillus Calmette-Guérin (BCG, Pasteur strain) was obtained from the Pasteur Institute (Paris). In cell cultures, it was used as such, heat killed (60°C for 60 min) or cobalt irradiated at 2 megarads (co-irr). The M. leprae used was always cobalt irradiated (2 megarads) because of legal restrictions on the use of the live form due to its pathogenicity in man. Guinea pigs weighing about 450 g were injected intradermally on the dorsum of the ear with 1  10 7 BCG, a live attenuated vaccine or 1  10 9 co-irr M. leprae in 0.05 ml saline. Autologous peritoneal exudate cells were used as antigen presenting accessory cells. Animals were injected intraperitoneally with 20 ml paraffin oil and on the fourth day the washing from the peritoneal cavity was collected and immediately centrifuged at 400g for 10 min to remove the oil, washed twice with plain culture medium and suspended in complete medium (10 6 viable cells/ ml) for further use. The draining post auricular (PA) and cervical (CER) lymph nodes were collected 2 weeks after immunization in the case of BCG (unless otherwise stated) and after 5 weeks in the case of M. leprae. Hematoxylin and eosin staining of histological sections and electron microscopy of the lymph nodes were done as described by Narayanan et al. [36] . They were cut into small pieces in Hank's Balanced Salt Solution (HBSS), gently teased to release the cells and the suspension of cells was passed through a steel wire mesh to remove the cell debris. Cells thus obtained were washed three times with HBSS at 400 g and re-suspended (2.5  10 6 viable cells per ml) in complete medium (RPMI-1640 supplemented with 10% fetal calf serum, 100 IU/ml penicillin, 100 lg/ml streptomycin, 4 mM L-glutamine and 2 mM sodium pyruvate). 5  10 5 of these cells in 200 ll were cultured in 96-well round-bottom plates with 25 lg/ml PPD, 10 lg/ml leprosin for 66 h or 3 lg/ml Con A for 72 h at 37°C in the presence of 5% CO 2 . 1 lCi 3 H thymidine (Amersham International) was added 24 h before harvesting and the uptake was estimated using liquid scintillation counter (Packard, Berks UK) [37, 38] . Cells were also cultured in the presence of live BCG, heat-killed BCG or co-irr BCG for five days, pulsed with thymidine and harvested as above. All cell cultures were done in quadruplicates. The results are expressed as stimulation index (T/C) defined as counts/min of 3 H thymidine uptake by proliferated cells divided by the counts/min of unstimulated cells. Thus, T/C expresses the extent of proliferation of sensitized T cells relative to nonsensitized, unstimulated cells when cultured with antigen or mitogen. Additionally, indomethacin was added in the cell culture to check whether the BCG induced suppression was prostaglandin mediated. Indomethacin (Sigma UK) was dissolved in ethanol at a concentration of 20 mg/ml, the solution was diluted with excess PBS to 500 lg/ml and filter sterilized. When required, 10 lg/ml of indomethacin was added to cell cultures. To identify which fraction of the cell population of the cervical lymph node was responsible for the observed lack of proliferation, the total cells were separated into adherent and non-adherent fractions using a nylon wool (NW) column, a rapid, single step and cost effective procedure for the separation of high viability T cells that flow out in the non-adherent fraction, from heterogeneous mononuclear cell preparations [35, 36, 39] . Briefly, 10 8 cells in 4 ml complete medium were incubated for 45 min in the NW column that was pre-incubated for 1 h with 5% fetal calf serum. The NW non-adherent cells that are enriched in T cells were eluted with 5% fetal calf serum, washed and suspended in complete medium. Subsequently, the adherent cells were released by teasing the nylon wool and eluting them out. The non-adherent and adherent cells were suspended separately at concentration 5  10 6 viable cells/ml in complete medium for further use. The non-adherent and adherent cell populations were mixed at ratios of 0:100, 25:75, 50:50, and 100:0 in 96 cell culture plates to make a total of 5  10 5 cells per well in 100 ll complete medium. These were cultured in quadruplicates in the presence of 25 lg/ml PPD as the antigen and 5  10 5 irradiated (1800 rads) autologous PECs as the antigen presenting cells (Section 2.6). Cell phenotypes present in the NW adherent fraction of the cervical lymph node cells from BCG injected guinea pigs were identified after staining them with respective antibodies. 1  10 6 NW adherent cells were incubated for 30 min in 100 ll of the following anti guinea pig cell monoclonal antibodies [37, 40] : MSgp7, pan T marker antibodies; CT6, putative T suppressor cell marker antibodies (Free University Amsterdam); MSgpM, anti-macrophage antibodies; CT9 (B cell marker). The cells were washed with PBS and incubated for 30 min with fluorescein isothiocyanate labeled anti mouse IgM or IgG (dilution 1:20, Sigma, UK) and the number of positive cells was estimated on a flow cytometer (FACS-1, Becton-Dickinson, Rutherford, N.J., USA). To elucidate the relative involvement of either T cells or macrophages (isolated in the NW adherent fraction of the cervical lymph node) in the suppression of cell proliferation, enriched fractions of each of the two populations were prepared by depleting the other using immunomagnetic separation. 10-15  10 6 cells from the adherent fraction were incubated with 0.5 ml of MSgpM or MSgp7 for 30 min, washed and incubated with magnetic beads coated with sheep anti mouse IgG (for MSgpM) or anti mouse IgM (for MSgp7) (Dynal, Oslo, Norway), for 20 min at 4°C. The number of beads added was 3-4 per positively labeled cells (Section 2.9). The suspension was diluted 5-10 times with Hank's balanced salt solution containing 1% fetal calf serum and placed on a cobaltsamarium magnet (Magnetic Development, Swindon, Wilts, UK) that attracted the rosetted cells to the sides of the tube (Fig. 1) . The unrosetted cells were decanted off and the process was repeated. Therefore, cells in the decanted fraction contained either the T cell enriched or the macrophage enriched fraction which were subsequently added separately to the non-adherent T cells (2.5  10 5 cells adherent cells plus 2.5  10 5 cells non-adherent cells). The final cell mixtures were cultured in quadruplicates with 25 lg/ml PPD in the presence of 1  10 5 irradiated PECs as antigen presenting cells (Section 2.8). The effects of injected BCG and M leprae on the stimulation index (T/C) measured in the post auricular and cervical lymph node cell preparations cultured with PPD, leprosin, concavalin A, or BCG: live, heat killed or co-irr were compared using student's t-test for means comparison. Since the BCG and M. leprae were injected to different animals the independent samples t-test was applied. Depending on the result of the equality of variances Levene's test the appropriate degrees of freedom were used. Differences in the T/C means were considered significant at the p < 0.05 level. The measurements are represented as means ± SD. All statistical analyses were conducted using SPSS 20 statistical software (IBM Inc., Chicago, IL, USA, Version 25.0, 2019). For non-linear model fitting and graphical presentations SigmaPlot for Windows 12.5 (Systat Software Inc. San Jose, California, US) was used. In Fig. 2 , granulomas in the draining post auricular lymph nodes formed after injection of live BCG or co-irradiated M. leprae on the dorsum ear are shown. Histological sections stained with Hematoxylin & Eosin showed maximum infiltration at 2 weeks for BCG and at 5 weeks for M. leprae. At these times, the draining cervical lymph nodes showed no granuloma formation but extensive lymphoproliferation. Fig. 2a shows a section of a distinct BCG draining granuloma in the post auricular lymph node consisting of large cells with epithelioid cell morphology surrounded by lymphocytes and fibroblasts. No acid-fast bacilli were detected. Fig. 2b shows an enlarged image of an epithelioid cell in the BCG granuloma with characteristic large nuclei, prominent nucleoli and swollen stacked rough endoplasmic reticulum (arrows). Fig. 2c shows a histological section of an M leprae granuloma. The majority of infiltrating cells are phagocytic macrophages. Fig. 2d shows an enlarged image of a macrophage with extensive vacuolation and degraded, undigested remains of M. leprae (arrow). The above findings were in accordance with the results of previous works [36, 41] . Fig. 3B corresponding bar plots are shown in the presence of a non-specific mitogen Con A. From Fig. 3A it appears that except for PA lymph node cells with PPD, T/C is much lower for animals injected with BCG than M. leprae (compare bars b with d in both groups and a with c in the second). In other words, the cells from BCG injected animals responded to a lesser extent to specific antigens compared with M. leprae. This is particularly obvious for the responses of the cervical lymph nodes cells. The differences were also confirmed by statistical analysis (Table 1) . Except for the PA cells with PPD, the responses of BCG and M leprae injected animals were significantly different for PA with leprosin (p = 0.025), for CER with PPD (p = 0.032) and for CER with leprosin (p = 0.002). On the other hand, in the presence of Con A (graph 3B), the cells from the BCG injected animals proliferated extensively (Y-axis scale in 3B is x10 larger than in 3A), indicating that otherwise the cells were active and responsive. Furthermore, addition of 10 lg/ml indomethacin did not enhance Vaccine xxx (xxxx) xxx the response of the BCG cervical lymph node cells to PPD (first group, lower of the two stacked bars in b), signifying that the suppression was not prostaglandins mediated. The comparatively elevated responses of M. leprae draining lymph nodes to mycobacterial antigens may be an outcome of the excessive inflammatory infiltration observed in vivo and was not further analyzed due to reasons explained below. Also, the lower response of these lymph nodes to Con A has been addressed by Gupta et al. [37] . To further examine whether the response of BCG injected animals to antigens changes with harvesting time, the stimulation index (T/C) at two and five weeks after BCG injection (10 7 ) to guinea pigs was compared and the results are presented in Table 2 . It can be seen that PA lymph node cells responded to PPD both at two and five weeks after injection (T/C from 3.21 to 4.4, and from 1.17 to 5.35 respectively) and the responses at the two harvesting times were not statistically different (t-test, p = 0.768). Additionally, the data in Table 2 show that the responses of the cervical lymph node cells both after two and five weeks remained low (from 0.74 to 1.24, and from 0.88 to 1.28) and not significantly different (t-test, p = 0.320). Following the unresponsiveness of BCG induced cervical lymph nodes to soluble mycobacterial antigens, it was thought worthwhile to check the response of lymph node cells of BCG and M. leprae injected animals to whole BCG organisms. Differently processed whole BCG bacteria (10 7 ) (live, heat killed or co-irr) were used, representing three different states. The results of the cell proliferative responses expressed as stimulation indices (T/C) are presented in Fig. 4 . In each group, the first two bars (a, b) correspond to BCG and the last two (c, d) to M. leprae induced lymph node cells. It is seen that for the BCG injected animals the cells from PA and the CER lymph nodes gave T/C between 3 and 4, i.e. they responded 3-4 times more than the starting population. This is in contrast to the previously observed unresponsiveness to soluble antigens (Fig. 3) , signifying the presence in the lymph nodes of cells reactive to whole BCG. No significant differences are seen in Fig. 4 between the responses of BCG draining PA and CER lymph nodes (compare bars a and b in each group). Regarding the response from M. leprae injection, with the exception of PA lymph nodes to heat killed mycobacteria, T/C ranged between 3.2 (live, bar c) and 8.1 (live, bar d) indicating greater overall proliferation than BCG. Statistical analysis (t-test) was conducted to identify significant differences between the T/C of PA or CER lymph node cells for BCG and M. leprae injected animals with live, heat killed and co-irr BCG mycobacteria. The results in Table 3 show that BCG induced significantly lower response in the CER lymph nodes than M. Leprae (p = 0.044) as it was also the case with the response to soluble mycobacterial antigens (Fig. 3) . However, BCG induced higher PA lymph node responses compared to M. leprae in the heat killed form (Fig. 4) bars a and c in the second group) (p = 0.005) which contradicts the results on soluble antigens, indicating different Table 1 Statistical analysis (means comparison, t-test) of the effects of BCG and M. leprae injected in the ear on the stimulation index (T/C) of post auricular and cervical lymph node cells in the presence of PPD or leprosin. Proliferative responses expressed as stimulation index (T/C, mean ± SD) from the post auricular and cervical lymph node cells of guinea pigs to PPD, two and five weeks after injection with 10 7 BCG. responses of BCG and M. leprae draining lymph nodes to the heatkilled form of BCG mycobacteria. Particularly, this may be due to the inability of proper digestion and presentation in culture in vitro. More studies on M. leprae induced granulomas were not further pursued because of dearth of supply of this mycobacterium. To elucidate which cells of the BCG draining cervical lymph node caused suppression of proliferation and lowering of the stimulation index (T/C) described above, they were separated into two fractions, the nylon wool (NW) adherent and the NW nonadherent. Then, the two fractions were mixed at different ratios and the T/C with PPD was determined using PECs as accessory antigen presenting cells. The results are presented in Fig. 5 where it can be seen that the non-adherent cells proliferated up to a T/C of 16 when cultured without the adherent, but with increasing proportion (X) of adherent cells the index decreased exponentially. The relationship is described by Eq. (1) with excellent fitting of the data as indicated by the value of the coefficient of determination (R 2 = 0.999). T=C ¼ 3:20 þ 12:70e ðÀ0:070XÞ ð1Þ The sudden drop of proliferation reaching T/C of about 5 at only 20% proportion of adherent cells, ==signifies their important role in suppression. To further demonstrate the strong abrogative effect of the adherent cells an experiment was conducted using of 2.5  10 5 non-adherent cells, the same number as that in the 50% mixture (point c'), but in the absence of adherent cells (b'). As it can be seen from the dotted line in Fig. 5 , the T/C obtained was 12.8, which is about 3.5 times higher than the T/C of 3.6 obtained with the same number 2.5  10 5 non-adherent cells but mixed with equal number of adherent (point c'). This result clearly signifies the strong suppressive effect of the NW adherent fraction of the BCG draining cervical lymph nodes cells. To elaborate the cell phenotypes that were present in the NW adherent fraction of the BCG induced cervical lymph nodes they were labeled with monoclonal antibodies specific for major cell populations found in the guinea pig lymph nodes. These included MSgp7 (pan, total T cells); CT6 (T suppressor cells); MSgpM (macrophages); MSgp9 (B cells). The proportions of the cell phenotypes in the NW adherent fraction of cells from the cervical lymph node are presented in Table 4 . The majority were macrophages (total 46.6%) and B cells (total 32.8%) followed by T lymphocytes (totals 16.6%) which consisted mostly of the suppressor lineage (14%), as they labelled with CT6, a putative suppressor cell marker. The 4% difference of the total (96%) from 100% can be ascribed to a small population of immature or other cells that did not stain with any of the antibodies. It can be noticed that all pan T cells consisted of suppressor/cytotoxic subtype. Differences in the percentages of MSgp7/CT6 among animals may be ascribed to inter-subject variation. Table 3 Statistical analysis (means comparison, t-test) of the effects of BCG and M. leprae injection on the stimulation index (T/C) of post auricular and cervical lymph node cells in the presence of live, heat killed or co-irr BCG. Levene's test 'Student's' t-test Since the results of the phenotypic analysis showed that the NW adherent population of cells from BCG stimulated cervical lymph nodes consisted of T cells (16.6%) and macrophages (46.6%), it was of interest to further look into their role in suppression. For this purpose, enriched cell populations of (i) T cell enriched and (ii) macrophage enriched were prepared from the adherent fraction by immunobead enrichment (Section 2.10). These were added to the non-adherent (1:1 ratio) in the final cultures. Thus, the total number of cells in the resulting cultures was 2.5  10 5 enriched adherent (either T cell enriched or macrophages enriched), 2.5  10 5 non-adherent, 1  10 5 PECS and PPD (25 lg/ml). In Fig. 6 are presented the proliferative responses expressed as counts/min of non-adherent cells alone, non-adherent cells with the T cell enriched fraction from the adherent population and non-adherent cells with the macrophage enriched fraction from the adherent population. Although there is large inter-subject variability, in 4 out of the five experimental animals, it is seen that when the T cells or macrophages were present individually in the culture, the proliferative response was enhanced. This is more pronounced with the macrophages enriched culture. Therefore, T cells or macrophages individually increased proliferation, whereas their co-existence in the NW adherent fraction caused immunosuppression as shown by the reduction of the stimulation index in Fig. 5 . In 1981, Narayanan et al demonstrated that intradermal injection of mycobacteria in the ear of guinea pigs caused the formation of granulomas in the draining PA lymph nodes while the CER lymph nodes showed no granuloma but extensive blastogenesis. The BCG draining granulomas were analogous to tuberculoid (immunological) leprosy lesions and the M. leprae draining granulomas analogous to lepromatous (non-immunological) leprosy lesions [42] . Therefore, these became excellent models for studying mycobacteria induced granuloma formation and immune responses in an animal model that was not possible in patients. The present study showed that contrary to M. leprae injected guinea pigs, cells from the cervical lymph nodes draining BCG induced granuloma did not respond in vitro to soluble mycobacterial antigens, PPD and leprosin, though they responded to whole BCG organisms. The observed suppression was neither due to prostaglandins (addition of indomethacin did not increase the stimulation index (T/C), Fig. 3 ) nor early harvesting of cells from the lymph nodes. Interestingly, these cervical lymph nodes did contain PPD reactive T cells as was confirmed when the latter were cultured with the antigen in the presence of autologous accessory antigen presenting cells. Additionally, neither the adherent macrophage fraction nor the adherent T cell fraction individually suppressed the response of the T cells, signifying that their synergistic action was required. In humans, BCG vaccination provides long-term imprinting of suppressor T regulatory phenotypes with low inflammation [43] . Similarly, suppressor macrophages have also been demonstrated in a number of studies involving mycobacteria and other intracellular pathogens [44, 45] . Their mode of suppression may be through direct contact with lymphocytes or by releasing suppressive mediators [46, 47] . It has also been demonstrated that macrophages and T cells may act together in concert to induce suppression of other cell functions [48] [49] [50] [51] . In the present investigation, the in vitro suppression observed in the cervical lymph node cells was not due to classical tolerance to the antigen, because cells from the adjacent PA lymph nodes showed marked responses. Therefore, an immune-controlling regulatory mechanism must operate in the cervical lymph nodes of guinea pigs injected with BCG but not with M. leprae. And, this must boost the early resolution at 2 weeks post injection along with progressive replacement of the infiltrated areas by fibrosis and decrease in the lymph nodes weight, signs indicating recovery. Similar self-contained lesions are observed in healthy human controls after BCG vaccination and, tuberculoid but not lepromatous leprosy where the lesions are of 'infiltrating' type and wide spread. It has therefore been implied that the suppressor activity in certain infections such as tuberculoid leprosy was generated as part of well-regulated immune response [52] . Thus, it is likely that the suppressor cells in the BCG induced cervical lymph nodes, as seen in this study, participate in the early resolving of the granulomas by controlling excessive proliferation or inflammation. The immune system is inherently a ''double-edged sword" and must be tightly regulated [53] . BCG vaccination offers heterologous protection against unrelated pathogens through altered responses to subsequent stimuli, termed ''trained immunity" [54] . Even though it is not clear to what extent guinea pigs can be infected by SARS-COV and SARS-CoV2 [55, 56] SARS-CoV-2 has been found to be immunogenic in these animals [57] [58] [59] . This has sparked interest in the use of BCG vaccine for potential new therapeutic uses and treatment of autoimmune diseases [52] . In the case of the current Covid-19 pandemic, in countries where BCG vaccination is obligatory, number of deaths due to infection, was reduced [28, 29] . Through an experimental model, the present work provides evidence for an induced regulatory mechanism and highlights the role of BCG in the regulation of a granuloma by the induction of immune suppressor cells. Finally, we show experimentally, the generation of an immunoregulatory mechanism that controls and resolves a granulomatous lymph node condition induced by BCG vaccination. Further characterization of the cell populations involved should be fascinating although it is practically beyond the immediate scope of this investigation. In this study, we show that two important cell populations namely, regulator (suppressor) T cells and macrophages function together in a process that lead to the 'immunological' character and early resolution of a granuloma in guinea pigs vaccinated intra dermally with BCG. For comparison purposes, results from a 'nonimmunological' granuloma induced in the same manner by another mycobacterium M. leprae are also presented. S.V. contributed the in vivo and in vitro experiments, interpretation of data and writing of the manuscript. I.N. contributed statistical analysis, interpretation of data and writing of the manuscript. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Training the trainable cells of the immune system and beyond Antigen processing and presentation to T cells Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing A suppressor B lymphocyte inhibiting IL-2 consumption in spleen cell cultures from Mycobacterium bovis BCG-infected mice CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells Suppressor adherent cells in human Hodgkin's disease. An immunodepleting and immunosuppressive disorder The resurrection of T cell-mediated suppression Requirement for histocompatible macrophages and lymphocytes Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung ATVB distinguished scientist award: how costimulatory and coinhibitory pathways shape atherosclerosis Exploring the full spectrum of macrophage activation How dying cells alert the immune system to danger Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production Macrophages in tissue repair, regeneration, and fibrosis IL-10 family of cytokines B-cell suppression of delayed hypersensitivity reactions Immune suppression with supraoptimal doses of antigen in contact sensitivity: I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide B-cell-mediated regulation of delayedtype hypersensitivity Activation of suppressor T cells by autologous lymphoblastoid cells: a mechanism for feedback regulation of immunoglobulin synthesis Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis Comparison of mycobacterial granulomas guinea-pig lymph nodes BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality BCG-induced cross-protection and development of trained immunity: implication for vaccine design Pathophysiology of COVID-19: Why Children Fare Better than Adults? Netea Mihai G. Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage. 2020 A Multivariable Analysis Vaccines Experimental mycobacterial granulomas in guinea pig lymph nodes: Ultrastructural observations Accessory cell function of cells of the mononuclear phagocyte system isolated from mycobacterial granulomas Accessory cell function of dendritic cells from lymph nodes containing mycobacterium leprae induced granulomas Separation of lymphoid cells on nylon wool columns Phenotypic analysis of guinea pig langerhans cells with antibodies directed against leucocyte surface antigens Macrophage specific antigen is expressed by resting microglia in the CNS but not by Langerhans cells in the skin The origin, morphology, and function of epithelioid cells Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis Immunology and immunopathology of African trypanosomiasis Immunosuppression effected by macrophage surfaces Regulation of the immune response by prostaglandins The evolution of immunosuppressive cell populations in experimental mycobacterial infection Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice Mechanisms of action of Mycobacterium bovis BCGinduced suppressor cells in mitogen-induced blastogenesis Regulatory role of FcR+ and FcRmonocyte subsets in mycobacterium leprae-induced lymphoproliferative response in vitro Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy An integrated view of suppressor T cell subsets in immunoregulation BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients Comparison of SARS-CoV-2 spike protein binding to human, pet, farm animals, and putative intermediate hosts ACE2 and ACE2 receptors Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARSCoV-2 Immunogenicity of a DNA vaccine candidate for COVID-19 Part of this article is from the PhD Thesis of Dr S. Vergkizi conducted at the Royal College of Surgeons of the University of London. The work was funded by the British Leprosy Relief Association (LEPRA) and is dedicated to late Prof John L. Turk and late Dr Jill Curtis, stalwarts in mycobacterial research of that time.